On Demand Learning

18 Results

  • Q&A Session - Telehealth for Opioid Use Disorder during the COVID-19 Pandemic and Beyond

    Contains 3 Component(s)

    This is the third webinar in the telehealth series for the Opioid Response Network (ORN). There have been significant telehealth legal, regulatory, and reimbursement changes at the federal and state level in the context of the COVID-19 pandemic. These changes have allowed for a rapid expansion of telehealth nationally, including for the assessment and treatment of mental health and substance use disorders. This webinar, hosted by the American Osteopathic Academy of Addiction Medicine through a Opioid Response Network STR-TA grant, will cover the telehealth legal, regulatory, clinical, and reimbursement landscape prior to and during the pandemic. The webinar will focus on telehealth for the treatment of opioid use disorder and will include an overview of key laws and regulations including the Ryan Haight Act, the Substance Use–Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act, and relevant changes made during the national public health emergency (PHE). The webinar will include a discussion of what the future telehealth landscape may look like once the national PHE and state-by-state executive orders and emergency declarations are lifted. Funding for this initiative was made possible (in part) by grant no. 6H79TI080816 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.

  • Telehealth for Opioid Use Disorder during the COVID-19 Pandemic and Beyond

    Contains 3 Component(s)

    This is the third webinar in the telehealth series for the Opioid Response Network (ORN). There have been significant telehealth legal, regulatory, and reimbursement changes at the federal and state level in the context of the COVID-19 pandemic. These changes have allowed for a rapid expansion of telehealth nationally, including for the assessment and treatment of mental health and substance use disorders. This webinar, hosted by the American Osteopathic Academy of Addiction Medicine through a Opioid Response Network STR-TA grant, will cover the telehealth legal, regulatory, clinical, and reimbursement landscape prior to and during the pandemic. The webinar will focus on telehealth for the treatment of opioid use disorder and will include an overview of key laws and regulations including the Ryan Haight Act, the Substance Use–Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act, and relevant changes made during the national public health emergency (PHE). The webinar will include a discussion of what the future telehealth landscape may look like once the national PHE and state-by-state executive orders and emergency declarations are lifted. Funding for this initiative was made possible (in part) by grant no. 6H79TI080816 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.

  • Essentials: Prescribing Naloxone to Patients for Overdose Reversal

    Contains 4 Component(s), Includes Credits

    This lecture is designed to provide the learner with brief history of the events in the late 1990s that resulted in today's opioid epidemic, discuss the epidemiology of opioid overdose and the neurobiology of overdose. Risk factors for overdose, the use of naloxone for overdose, and state laws regarding prescribing naloxone will be discussed.

  • Essentials: Alcohol Use Problems: Recommendations for Medical Management

    Contains 4 Component(s), Includes Credits

    Alcohol is the most commonly used intoxicant in the world. There are a variety of physical, behavioral, and societal problems that can result from drinking alcohol in a risky or dependent pattern. This presentation will review some of t the development components, the acute treatments, and the long term treatments available. The program will stress the importance of a longitudinal approach to the treatment of the effected patient.

  • Essentials: 12 Step Program

    Contains 4 Component(s), Includes Credits

    We explain why 4-5 million people use 12 step methods & more people are seeking help for addiction to drugs and alcohol.

  • Essentials: Psychosocial Treatments for Substance Use Disorder

    Contains 4 Component(s), Includes Credits

    This lecture will review the co-morbid medical and behavioral treatments in the field of addiction medicine. Addiction Medicine patients have a higher rate of medical and psychiatric disorders and this often complicates the treatment of the addiction. Screening and evaluation process for medical and behavioral issues will be reviewed. Screening tools for PTSD, Depression and the Mental Status Examination will be reviewed in detail. Medical screening laboratory and toxicology screens will be discussed. Infectious disease evaluation and care is of critical importance in light of HIV, HEP C and other infectious processes. Treatment of chronic medical disorders including pain syndromes may complicate the treatment of addiction patients.